Nordic Group B.V. through its subsidiary Nordic Pharma Inc. announces launch of authorized generic of Maxitrol (neomycin and polymyxin B sulfates and dexamethasone ophthalmic suspension).

NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic‑focused healthcare company, today announced its acquisition of the exclusive U.S. commercialization rights of ...